Nanotechnology in Medicine II: Bridging Translational in vitro and in vivo Interfaces

An ECI Conference Series

June 5-9, 2018
Grande Real Santa Eulalia Hotel
Albufeira, Portugal

18AH

About This Conference

Following the success of the first two ECI conferences on nanotechnology in biology and medicine (Nanotechnology for the Study of Cellular and Molecular Interactions in 2009; Nanotechnology in Medicine: From Molecules to Humans in 2016), we set out to continue the series on Nanotechnology in Medicine with this third edition (2018).

Nanotechnology is increasingly prominent in medicine for various applications ranging from evaluation of cellular and molecular interactions determining drug efficacy to the downstream development of technologies for disease characterization, detection, and treatment. A few examples include systemically injectable nanoparticles for the targeted delivery of multiple therapeutic and contrast agents; multi-scale hierarchically-complex implants for the regeneration of bone and soft tissues; and micro/nano-fluidic chips mimicking physiological features of the innate environment. Despite its enormous promise, only a few nanotechnology platforms have seen clinical utility. A key limit to translation is the lack of mechanistic understanding, at multiple scales, of the integrated molecular, cellular, tissue-level, and higher order interactions of these technologies within the complex biological systems of health vs. disease.

The ECI Nanotechnology in Medicine II conference will expand upon the mission of its predecessor by providing a diverse and broadened platform to (i) deepen mechanistic understanding of the interactions and responses of nanotechnologies within biological systems at multiple scales; and (ii) exploit this understanding to generate highly effective nanotechnologies for the early detection, imaging, and treatment of human diseases.

In the present edition, the conference theme will focus on the challenges in design and integration of effective platforms for nanotechnology evaluation, ranging from cellular and subcellular analyses, to cell culture environments and 3D models of the cell niche, to lab-on-a-chip systems for analyzing interactions between multiple tissue or organ systems. To this end, we will increase the scope of the conference by adding new sessions underlining the exciting field of in vitro microfluidics as a tool to mimic physiological processes and thereby accelerate translation of nanotechnologies. A dedicated session on this topic will also serve as a timely venue to highlight a Special Issue to appear in the journal Biomicrofluidics (American Institute of Physics).

The conference aims to bring together a broad range of scientists covering the interdisciplinary fields of biology, chemical and bioengineering, material science, physics, and others. Moreover, the conference will devote a dedicated ‘industry session’ where selected companies will have an opportunity to give oral presentations in an effort to bridge academic research and industrial R&D.

Overall, the third chapter of this conference series will help to further discussions among the interdisciplinary nanotechnology in medicine community, while also fostering the development of new, synergistic collaborations between academic and industrial scientists.

Sessions:

  • Design Advances
  • Materials-Biology
  • Microfluidics
  • Cell Niche

Conference Organization

Conference Chairs:

     Millicent Sullivan, PhD
University of Delaware, USA
msulliva@udel.edu

 

 

     Josué Sznitman, Dr. Sc.
Technion-Israel Institute of Technology, Israel
sznitman@bm.technion.ac.il

 

 

Conference Co-Chairs:

     Lola Eniola-Adefeso, PhD
University of Michigan, USA

     

 

 

     Srivatsan Kidambi, PhD
University of Nebraska – Lincoln, USA

 

 

 

 

Conference Liaison:

     Joye Bramble, PhD
Morphotek, USA

 

 

 

Conference Program

Please click HERE to view the final program and posters.

Conference Brochure

Conference Awards

Young Scientist Awards

Nitzan Krinsky, Techion, Israel Institute of Technology, Israel

Synthetic cells synthesize therapeutic proteins inside tumors

Laura De Laporte, DWI-Leibniz Institute for Interactive Materials, Germany

Synthetic building block for hierarchical tissue engineering

Poster Awards

1st Place:  Nitzan Krinsky, Techion, Israel Institute of Technology, Israel

Synthetic cells synthesize therapeutic proteins inside tumors

2nd Place:  Raj Kumar Thapa, University of Delaware, USA

Development of a collagen-based scaffold for sequential delivery of antimicrobial agents and PDGF genes to chronic wounds

3rd Place:  Umberto Capasso Palmiero, Politenico di Milano, Italy

Polyester-based excipients to formulate lipophilic drugs into nanoparticles directly at the bed of the patient

General Information about ECI

Engineering Conferences International (ECI) is a global engineering conferences program, originally established in 1962, that provides opportunities for the exploration of problems and issues of concern to engineers and scientists from many disciplines.

The format of the weeklong research conference provides morning and late afternoon or evening sessions in which major presentations are made. Available time is included during the afternoons for ad hoc meetings, informal discussions, and/or recreation. This format is designed to enhance rapport among participants and promote dialogue on the development of the meeting. We believe that the conferences have been instrumental in generating ideas and disseminating information to a greater extent than is possible through more conventional forums.

All participants are expected both to attend the entire conference and to contribute actively to the discussions. The recording of lectures and presentations is forbidden. As ECI conferences take place in an informal atmosphere, casual clothing is the usual attire.

Engineering Conferences International
32 Broadway, Suite 314, New York, NY 10004
T: 1-7212-514-6760 – F: 1-212-514-6030

info@engconfintl.org – www.engconfintl.org